BCL2L1 and prostate cancer: Compound 7 was identified to bind to Bcl-xL (KD = 6.5 μM), inhibit cell growth (IC50 < 0.5 μM against all three cells), and induce autophagy in PC-3 and PC-3a prostate cancer cells.